Four states have already banned UHC-style accumulator policies. As state legislatures begin their 2021 sessions, the ACR contends that it is urgent for the AMA to have a clear policy to support accumulator ban legislation that protects patient access to critical therapies.
The ACR considers and introduces resolutions at AMA meetings based on its positions and policies and the work of key ACR committees and the Board of Directors. ACR members are asked to help this work to advance rheumatology issues by joining the AMA and renewing their AMA memberships each year. Rheumatology’s voice at the House of Delegates meeting is determined based on the number of ACR members who are also members of the AMA, so every single person who is both an ACR and an AMA member adds to the strength of this effort. Join or renew your AMA membership before 2020 comes to a close and receive valuable membership benefits along with helping to advance rheumatology.
The ACR’s delegation to the AMA House of Delegates consists of Gary Bryant, MD (Delegate and Delegation Chair), Eileen Moynihan, MD (Delegate), Colin Edgerton, MD (Alternate Delegate), Cristina Arriens, MD (Alternate Delegate), Luke Barre, MD (Young Physician Section representative), Christina Downey, MD (Young Physician Section representative), and Rami Diab, MD (Resident and Fellows Section representative). Questions and suggestions for the AMA delegation’s work on behalf of the rheumatology can be directed to [email protected].
